Co-Diagnostics, Inc. (OTC: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that ...

Co-Diagnostics, Inc. (OTC: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that it ...

Company and CoSara believe that ISO certification is a critical component of the regulatory requirements for clearance of new ...

The growth of the genomics market is driven by the rising prevalence of genetic disorders and cancer, along with increasing awareness of early disease detection through genetic testing. WILMINGTON, ...

In areas where the nearest emergency room is far away, how can responders give patients the best possible care when time is ...

The Commerce Commission has published a statement of issues relating to an application from Rafting JV Co seeking clearance to acquire the rafting and sledging assets of Rotorua Rafting, Kaitiaki ...

FOSHAN, GUANGDONG, CHINA, January 26, 2026 /EINPresswire.com/ -- The global industrial landscape is experiencing a ...

WOBURN, MA, UNITED STATES, February 9, 2026 /EINPresswire.com/ -- Powered by AFA‑enabled workflows that deliver ...

NINGBO, ZHEJIANG, CHINA, January 21, 2026 /EINPresswire.com/ -- Ningbo Scientz Biotechnology Co., Ltd., a leading ...

The global development of civilization diseases is a challenge that requires many modern solutions, not only in terms of treatment, but first and foremost in terms of early diagnostics. One of the ...

( OTCQB: BIXT) today announced positive clinical results from its recently completed Phase 2 randomized, double-blind, placebo-controlled, dose-optimization trial evaluating ProLectin-M in subjects ...

CHONGYANG CITY, HUBEI PROVINCE, CHINA, February 9, 2026 /EINPresswire.com/ -- The global packaging industry stands at a ...